EGFR and adenocarcinoma: In all major sample groups (adenocarcinoma, SqCC, and NSCLC-NOS) TP53 was the most frequently mutated gene, while the mutational pattern for KRAS and EGFR (second and third most frequently mutated genes in total) differed between sample/histological groups (Figure 2B).